-
8
-
-
0345145203
-
-
G. Gumina, Y. Chong, H. Choo, G.-Y. Song, and C.K. Chu Curr. Top. Med. Chem. 2 2002 1065
-
(2002)
Curr. Top. Med. Chem.
, vol.2
, pp. 1065
-
-
Gumina, G.1
Chong, Y.2
Choo, H.3
Song, G.-Y.4
Chu, C.K.5
-
9
-
-
0028943355
-
-
C.K. Chu, T. Ma, K. Shanmuganathan, C. Wang, Y. Xiang, S.B. Pai, G.-Q. Tao, J.-P. Sommadossi, and Y.-C. Cheng Antimicrob. Agents Chemother. 39 1995 979 Clevudine has been marketed in South Korea and the philippines under the trade names Levovir and Revovir, but phase III clinical trials in the U.S. have been discontinued
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 979
-
-
Chu, C.K.1
Ma, T.2
Shanmuganathan, K.3
Wang, C.4
Xiang, Y.5
Pai, S.B.6
Tao, G.-Q.7
Sommadossi, J.-P.8
Cheng, Y.-C.9
-
10
-
-
0029881506
-
-
T.-S. Lin, M.-Z. Luo, M.-C. Liu, Y.-L. Zhu, E. Gullen, G.E. Dutschman, and Y.-C. Cheng J. Med. Chem. 39 1996 1757
-
(1996)
J. Med. Chem.
, vol.39
, pp. 1757
-
-
Lin, T.-S.1
Luo, M.-Z.2
Liu, M.-C.3
Zhu, Y.-L.4
Gullen, E.5
Dutschman, G.E.6
Cheng, Y.-C.7
-
11
-
-
0030598664
-
-
P.J. Bolon, P. Wang, C.K. Chu, G. Gosselin, V. Boudou, C. Pierra, C. Mathé, J.-P. Imbach, A. Faraj, M.A. el Alaoui, J.-P. Sommadossi, S.B. Pai, Y.-L. Shu, J.-S. Lin, Y.-C. Cheng, and R.F. Schinazi Bioorg. Med. Chem. Lett. 6 1996 1657
-
(1996)
Bioorg. Med. Chem. Lett.
, vol.6
, pp. 1657
-
-
Bolon, P.J.1
Wang, P.2
Chu, C.K.3
Gosselin, G.4
Boudou, V.5
Pierra, C.6
Mathé, C.7
Imbach, J.-P.8
Faraj, A.9
El Alaoui, M.A.10
Sommadossi, J.-P.11
Pai, S.B.12
Shu, Y.-L.13
Lin, J.-S.14
Cheng, Y.-C.15
Schinazi, R.F.16
-
12
-
-
79955862289
-
-
http://clinicaltrials.gov/search/term=Elvucitabine.
-
-
-
-
13
-
-
0035172399
-
-
M.L. Bryant, E.G. Bridges, L. Placidi, A. Faraj, A.-G. Loi, C. Pierra, D. Dukhan, G. Gosselin, J.-L. Imbach, B. Hernandez, A. Juodawlkis, B. Tennant, B. Korba, P. Cote, P. Marion, E. Cretton-Scott, R.F. Schinazi, and J.-P. Sommadossi Antimicrob. Agents Chemother. 45 2001 229
-
(2001)
Antimicrob. Agents Chemother.
, vol.45
, pp. 229
-
-
Bryant, M.L.1
Bridges, E.G.2
Placidi, L.3
Faraj, A.4
Loi, A.-G.5
Pierra, C.6
Dukhan, D.7
Gosselin, G.8
Imbach, J.-L.9
Hernandez, B.10
Juodawlkis, A.11
Tennant, B.12
Korba, B.13
Cote, P.14
Marion, P.15
Cretton-Scott, E.16
Schinazi, R.F.17
Sommadossi, J.-P.18
-
14
-
-
33645048707
-
-
J.W. Kim, S.H. Park, and S.G. Louie Ann. Pharmacother. 40 2006 472 Telbivudine is marketed by Swiss pharmaceutical company Novartisunder the trade names Sebivo (Europe) and Tyzeka (United States)
-
(2006)
Ann. Pharmacother.
, vol.40
, pp. 472
-
-
Kim, J.W.1
Park, S.H.2
Louie, S.G.3
-
15
-
-
17644371039
-
-
Y. Huang, S. Ostrowitzki, G. Hill, M. Navarro, N. Berger, P. Kopeck, C.I. Mau, T. Alfredson, and R. Lal J. Clin. Pharmacol. 45 2005 578
-
(2005)
J. Clin. Pharmacol.
, vol.45
, pp. 578
-
-
Huang, Y.1
Ostrowitzki, S.2
Hill, G.3
Navarro, M.4
Berger, N.5
Kopeck, P.6
Mau, C.I.7
Alfredson, T.8
Lal, R.9
-
16
-
-
0034090556
-
-
R.C. Tam, K. Ramasamy, J. Bard, B. Pai, C. Lim, and D.R. Averett Antimicrob. Agents Chemother. 44 2000 1276
-
(2000)
Antimicrob. Agents Chemother.
, vol.44
, pp. 1276
-
-
Tam, R.C.1
Ramasamy, K.2
Bard, J.3
Pai, B.4
Lim, C.5
Averett, D.R.6
-
17
-
-
0003049487
-
-
G.W. Koszalka, S.D. Chamberlain, R.J. Harvey, L.W. Frick, S.S. Good, M.L. Davis, A. Smith, K.K. Biron, J.C. Drach, and L.B. Townsend Antiviral Res. 30 1996 43
-
(1996)
Antiviral Res.
, vol.30
, pp. 43
-
-
Koszalka, G.W.1
Chamberlain, S.D.2
Harvey, R.J.3
Frick, L.W.4
Good, S.S.5
Davis, M.L.6
Smith, A.7
Biron, K.K.8
Drach, J.C.9
Townsend, L.B.10
-
19
-
-
0037173068
-
-
B. Wlotzka, S. Leva, B. Eschgfaller, J. Burmeister, F. Kleinjung, C. Kaduk, P. Muhn, H. Hess-Stumpp, and S. Klussmann Proc. Natl. Acad. Sci. U.S.A. 99 2002 8898
-
(2002)
Proc. Natl. Acad. Sci. U.S.A.
, vol.99
, pp. 8898
-
-
Wlotzka, B.1
Leva, S.2
Eschgfaller, B.3
Burmeister, J.4
Kleinjung, F.5
Kaduk, C.6
Muhn, P.7
Hess-Stumpp, H.8
Klussmann, S.9
-
20
-
-
59349098795
-
-
For a review on l-ribose: K. Okano Tetrahedron 65 2009 1937
-
(2009)
Tetrahedron
, vol.65
, pp. 1937
-
-
Okano, K.1
-
23
-
-
0032971045
-
-
J. Du, Y. Choi, K. Lee, B.K. Chun, J.H. Hong, and C.K. Chu Nucleosides Nucleotides 18 1999 187
-
(1999)
Nucleosides Nucleotides
, vol.18
, pp. 187
-
-
Du, J.1
Choi, Y.2
Lee, K.3
Chun, B.K.4
Hong, J.H.5
Chu, C.K.6
-
24
-
-
0036593354
-
-
M. Akagi, D. Omae, Y. Tamura, T. Ueda, T. Kumashiro, and H. Urata Chem. Pharm. Bull. 50 2002 866
-
(2002)
Chem. Pharm. Bull.
, vol.50
, pp. 866
-
-
Akagi, M.1
Omae, D.2
Tamura, Y.3
Ueda, T.4
Kumashiro, T.5
Urata, H.6
-
25
-
-
8944256416
-
-
T. Ma, S.B. Pai, Y.L. Zhu, J.S. Lin, K. Shanmuganathan, J. Du, C. Wang, H. Kim, M.G. Newton, Y.C. Cheng, and C.K. Chu J. Med. Chem. 39 1996 2835
-
(1996)
J. Med. Chem.
, vol.39
, pp. 2835
-
-
Ma, T.1
Pai, S.B.2
Zhu, Y.L.3
Lin, J.S.4
Shanmuganathan, K.5
Du, J.6
Wang, C.7
Kim, H.8
Newton, M.G.9
Cheng, Y.C.10
Chu, C.K.11
-
29
-
-
23044433521
-
-
M. Yun, H.R. Moon, H.O. Kim, W.J. Choi, Y.-C. Kim, C.-S. Park, and L.S. Jeong Tetrahedron Lett. 46 2005 5903
-
(2005)
Tetrahedron Lett.
, vol.46
, pp. 5903
-
-
Yun, M.1
Moon, H.R.2
Kim, H.O.3
Choi, W.J.4
Kim, Y.-C.5
Park, C.-S.6
Jeong, L.S.7
-
39
-
-
73249136791
-
-
G. Pushpakiran, Y. Akihide, M. Kenji, R. Devendar, A. Kazuya, F.J. Sarah, G.W.J. Fleet, and I. Ken Tetrahedron Lett. 51 2010 895
-
(2010)
Tetrahedron Lett.
, vol.51
, pp. 895
-
-
Pushpakiran, G.1
Akihide, Y.2
Kenji, M.3
Devendar, R.4
Kazuya, A.5
Sarah, F.J.6
Fleet, G.W.J.7
Ken, I.8
-
41
-
-
13144262401
-
-
H. Li, Y. Bleriot, J.-M. Mallet, Y. Zhang, E. Rodriguez-Garcia, P. Vogel, S. Mari, J. Jimenez-Barbero, and P. Sinay Heterocycles 64 2004 65
-
(2004)
Heterocycles
, vol.64
, pp. 65
-
-
Li, H.1
Bleriot, Y.2
Mallet, J.-M.3
Zhang, Y.4
Rodriguez-Garcia, E.5
Vogel, P.6
Mari, S.7
Jimenez-Barbero, J.8
Sinay, P.9
-
43
-
-
77955653859
-
-
M. Shiozaki, T. Tashiro, H. Koshino, R. Nakagawa, S. Inoue, T. Shigeura, H. Watarai, M. Taniguchi, and K. Mori Carbohydr. Res. 345 2010 1663
-
(2010)
Carbohydr. Res.
, vol.345
, pp. 1663
-
-
Shiozaki, M.1
Tashiro, T.2
Koshino, H.3
Nakagawa, R.4
Inoue, S.5
Shigeura, T.6
Watarai, H.7
Taniguchi, M.8
Mori, K.9
-
46
-
-
79955795815
-
-
note
-
l-Ribose was also confirmed by matching the NMR spectra of synthetic with commercially available Aldrich sample.
-
-
-
|